Skip to main content

GOLDMAN SACHS GROUP INC

Position in TCRX — TScan Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in TCRX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$37,639
-$49,264 QoQ
Shares Held
37,267
-57.1% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. TCRX ranks #349 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TCRX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $37,639 37,267
2025-12-31 $86,903 86,903
2025-09-30 $238,383 130,980
2025-06-30 $623,600 430,070
2025-03-31 $235,081 170,349
2024-12-31 $488,445 160,673
2024-09-30 $789,947 158,624
2024-06-30 $206,317 35,268
2024-03-31 $2,065,575 260,148
2023-12-31 $176,561 30,285
2021-09-30 $96,168 11,531